Rapid Onset of Nucleolar Segregation Followed by DNA Fragmentation in Roscovitine-Treated MCF-7 Cells Supports Its Pro-Apoptotic Potential

由 Kotala, V., Horky, M., Uldrijan, S., Strnad, M., Vojtesek, B.
發表在 ScientificWorldJournal (2001)

Intrinsic proteotoxic stress levels vary and act as a predictive marker for sensitivity of cancer cells to Hsp90 inhibition

由 Pastorek, M., Muller, P., Coates, P. J., Vojtesek, B.
發表在 PLoS One (2018)

Biochemical analysis of the stress protein response in human oesophageal epithelium

由 Hopwood, D, Moitra, S, Vojtesek, B, Johnston, D, Dillon, J, Hupp, T
出版 1997

Comparison between p53 staining in tissue sections and p53 proteins levels measured by an ELISA technique.

由 Vojtĕsek, B., Fisher, C. J., Barnes, D. M., Lane, D. P.
出版 1993

HLA-DR antigens on differentiating human mammary gland epithelium and breast tumours.

由 Bártek, J., Petrek, M., Vojtĕsek, B., Bártková, J., Kovarík, J., Rejthar, A.
出版 1987

Relation of Bcl-2 expression to androgen receptor, p21WAF1/CIP1, and cyclin D1 status in prostate cancer

由 Kolář, Z, Murray, P G, Scott, K, Harrison, A, Vojtěšek, B, Dušek, J
出版 2000

Novel phosphorylation sites of human tumour suppressor protein p53 at Ser20 and Thr18 that disrupt the binding of mdm2 (mouse double minute 2) protein are modified in human cancers...

由 Craig, A L, Burch, L, Vojtesek, B, Mikutowska, J, Thompson, A, Hupp, T R
出版 1999

TAp63gamma is required for the late stages of myogenesis

由 Cefalù, S, Lena, AM, Vojtesek, B, Musarò, A, Rossi, A, Melino, G, Candi, E
發表在 Cell Cycle (2015)

Problems with p53 immunohistochemical staining: the effect of fixation and variation in the methods of evaluation.

由 Fisher, C. J., Gillett, C. E., Vojtĕsek, B., Barnes, D. M., Millis, R. R.
出版 1994

Differences in p53 and Bcl-2 expression in relation to cell proliferation during the development of human embryos.

由 Lichnovský, V, Kolár, Z, Murray, P, Hlobilková, A, Cernochová, D, Pospísilová, E, Vojtĕsek, B, Nenutil, R
出版 1998

Absence of p53 autoantibodies in a significant proportion of breast cancer patients.

由 Vojtesek, B., Kovarik, J., Dolezalova, H., Nenutil, R., Havlis, P., Brentani, R. R., Lane, D. P.
出版 1995

Synthetic inhibitors of CDKs induce different responses in androgen sensitive and androgen insensitive prostatic cancer cell lines

由 Mad’arová, J, Lukešová, M, Hlobilková, A, Strnad, M, Vojtěšek, B, Lenobel, R, Hajdúch, M, Murray, P G, Perera, S, Kolář, Z
出版 2002

p53 isoforms regulate astrocyte-mediated neuroprotection and neurodegeneration

由 Turnquist, C, Horikawa, I, Foran, E, Major, E O, Vojtesek, B, Lane, D P, Lu, X, Harris, B T, Harris, C C
發表在 Cell Death Differ (2016)

A constitutional de novo mutation in exon 8 of the p53 gene in a patient with multiple primary malignancies.

由 Speiser, P., Gharehbaghi-Schnell, E., Eder, S., Haid, A., Kovarík, J., Nenutil, R., Sauter, G., Schneeberger, C. H., Vojtesek, B., Wiltschke, C. H., Zeillinger, R.
出版 1996

Identification and role of migration stimulating factor isoforms in breast carcinomas

由 Schor, AM, Ellis, IR, Jones, SJ, Perrier, S, Florence, MM, Cox, J, Ohe, G, Kankova, K, Vojtesek, B, Thompson, AM, Purdie, C, Kazmi, S, Foo, S, Woolston, AM, Schor, SL
出版 2008